A study on the effect of add-on rosiglitazone on the anklebrachial pressure index of patients with type 2 diabetes mellitus in hospital Universiti Sains malaysia

Background Rosiglitazone, an oral hypoglycaemic agent of the thiazolidinedione group is used for Type 2 Diabetes treatment. Research has shown that this medication, being a peroxisome proliferator activator receptor-gamma agonist has effects beyond glycaemic control alone. Apart from improving in...

Full description

Saved in:
Bibliographic Details
Main Author: Mustaffa, Nazri
Format: Thesis
Language:English
Published: 2007
Subjects:
Online Access:http://eprints.usm.my/48443/1/Dr.%20NAZRI%20MUSTAFFA.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!